In Quest of Tomorrow's Medicines
An eminent scientist talks about the pharmaceutical industry, biotechnology and the future of drug research. In the course of our busy, technologically-driven lives, it is taken for granted that we respond to minor fluctuations in our health by taking pills -- pills for headache and for toothache; sleeping pills and tranquilizers; pills to lower fever, quiet coughs, and clear the sinuses; medicines to reduce appetite; preparations to relieve heartburn; and many more. In the war against serious disease, medicines are an indispensable weapon in the physician's arsenal: they save lives, or at least prolong them and make them more bearable. Despite the important role that pharmaceuticals play in our lives, few of us know where medicines come from or how the pharmaceutical industry discovers and develops new drugs. Jurgen Drews, an acclaimed leader in the pharmaceutical industry, tells the fascinating story of drug discovery and development from his years of successfully leading internatnional research teams at Hoffman-LaRoche. Drews traces the history of modern drug development from pharmacies, chemical companies, and individual entrepeneurs in Switzerland, Germany and the U.S. to the mega-corporations that dot the landscape of Europe, Japan and America. He describes the process by which new drugs are tested and brought to market, including a provacative look at how AIDS activism stimulated the approval process in the US. Drews' commentary on the role of clinical trials -- the time involved and their cost -- is sobering testimony to the complexity of bringing innovation to the marketplace. In the final two chapters of "In Quest of Tomorrow's Medicines", Drews offers an important and critical analysis of research in the the pharmaceutical industry, pointing to strategies that work and management practices that impede progress. Drews' comments on the impact that the growing relationship between the biotechnology industry and university-sponsored research will have ont he pharmaceutical industry makes provocative reading for pharmaceutical researchers, managers and investors. "In Quest of Tomorrow's Medicines" in written in clear, thoughtful language for people in the pharmaceutical and biotechnology industries, as well as policy makers, industry analysts and observers.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Drugs Patients and the Pharmaceutical Industry
The History of the Pharmaceutical Industry Natural Substances as Drugs
Drug Research Merging Experimental Pharmacology and Chemistry
Technological Advances and a Paradigm Shift in Drug Research
A Medicine Is Born Research Development and Registration
Management of Innovation Directing Research and Development
Other editions - View all
acid active alkaloids already angiotensin animal antibiotics apothecaries application areas bacteria Basel basic research basis biochemical biotechnology biotechnology industry blood cells century chemical chemistry chemotherapy clinical combinatorial combinatorial chemistry companies compounds digitoxin discovery disease dosage drug research drug therapy Ehrlich enterprise enzyme established example experimental experiments Figure function gene therapy Genentech genetic genome genome research goals human ideas important infections inhibitors innovation institute large number lead medicine ment merger messenger RNA methods million molecular biology molecules monoclonal antibodies organs Oswald Schmiedeberg particular patients Paul Ehrlich percent pharmaceutical firms pharmaceutical industry pharmacology phase physicians physiology possible preclinical projects prontosil proteins quinine receptor recombinant research and development Roche role Schmiedeberg scientific scientists sequence side effects strategy structure studies substances success sulfanilamide synthesis targets tests thalidomide therapeutic tion toxic treatment United universities vectors